Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avricore Health (AVCRF) EBIT (2016 - 2025)

Historic EBIT for Avricore Health (AVCRF) over the last 17 years, with Q3 2025 value amounting to -$277210.9.

  • Avricore Health's EBIT fell 11609.71% to -$277210.9 in Q3 2025 from the same period last year, while for Sep 2025 it was -$606716.2, marking a year-over-year decrease of 86509.14%. This contributed to the annual value of $94222.3 for FY2024, which is 11833.78% up from last year.
  • Latest data reveals that Avricore Health reported EBIT of -$277210.9 as of Q3 2025, which was down 11609.71% from -$342079.5 recorded in Q2 2025.
  • Avricore Health's EBIT's 5-year high stood at $117610.1 during Q1 2024, with a 5-year trough of -$342079.5 in Q2 2025.
  • Moreover, its 5-year median value for EBIT was -$45013.1 (2021), whereas its average is -$80538.6.
  • In the last 5 years, Avricore Health's EBIT surged by 39542.43% in 2023 and then tumbled by 96541.81% in 2025.
  • Over the past 5 years, Avricore Health's EBIT (Quarter) stood at -$45013.1 in 2021, then tumbled by 290.68% to -$175856.1 in 2022, then soared by 128.68% to $50442.8 in 2023, then rose by 29.78% to $65466.6 in 2024, then tumbled by 523.44% to -$277210.9 in 2025.
  • Its last three reported values are -$277210.9 in Q3 2025, -$342079.5 for Q2 2025, and -$52892.5 during Q1 2025.